Ipsen S.A. (IPN.PA) News
Track canonical SquawkNews coverage tagged to IPN.PA, Ipsen S.A.. This hub brings together deduplicated headlines about paris, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Ipsen shares slide 7% as FDA approves generic Somatuline
Shares in Ipsen fell about 7% after the US Food and Drug Administration approved Amneal's generic version of the company's blockbuster drug Somatuline. Both J.P. Morgan and Jefferies see the FDA approval as increasing pr
EQUITY | Sep 21, 2026, 08:52 AM UTC
L
BRIEF — Ipsen Appoints Mariette Finet To Its Board Of Directors
Sept 18 (Reuters) — Ipsen SA: Ipsen Appoints Mariette Finet To Its Board Of Directors Source text:... Further company coverage: IPN.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;)
NEWS | Sep 18, 2026, 07:27 AM UTC
L
Ipsen names Mariette Finet to board, replacing Michèle Ollier
Ipsen co-opted Mariette Finet to its board, effective immediately, replacing Michèle Ollier, who resigned on Aug. 1. Finet, a physician, has 35+ years in healthcare, pharmaceuticals, and life sciences, including roles at
NEWS | Sep 18, 2026, 07:27 AM UTC